Clinical impact of EUS and EUS-FNA of bilateral adrenal glands in patients with potentially resectable lung cancer

Not Applicable

• Conditions: lung cancer

• Registration Number: JPRN-UMIN000007583
• Lead Sponsor: First Dept. of Internal Medicine, Gifu University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-04-01
• Study Completion: 2012-04-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

Not provided

Exclusion Criteria

The exclusion criteria were patients with poor medical conditions of grades 4 and 5 according to the American Society of Anesthesiologists Physical Status classification system, and patients with bleeding tendency and coagulopathy.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To assess the detection rate of right adrenal gland by EUS and to compare the accuracy between CT, PET-CT and EUS/EUS-FNA for adrenal metastases.

Secondary Outcome Measures

Name	Time	Method
To compare the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) between CT, PET-CT and EUS/EUS-FNA for adrenal metastases. To evaluate the incidence of EUS/EUS-FNA related complications.